vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and KKR Real Estate Finance Trust Inc. (KREF). Click either name above to swap in a different company.
KKR Real Estate Finance Trust Inc. is the larger business by last-quarter revenue ($25.8M vs $24.8M, roughly 1.0× Ceribell, Inc.). Ceribell, Inc. runs the higher net margin — -54.6% vs -101.7%, a 47.2% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.
CBLL vs KREF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $25.8M |
| Net Profit | $-13.5M | $-26.2M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | -105.1% |
| Net Margin | -54.6% | -101.7% |
| Revenue YoY | — | -26.6% |
| Net Profit YoY | — | -229.6% |
| EPS (diluted) | $-0.35 | $-0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $25.8M | ||
| Q3 25 | $22.6M | $25.3M | ||
| Q2 25 | $21.2M | $30.2M | ||
| Q1 25 | $20.5M | $31.3M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | $17.2M | $37.0M | ||
| Q2 24 | — | $40.4M | ||
| Q1 24 | — | $39.1M |
| Q4 25 | $-13.5M | $-26.2M | ||
| Q3 25 | $-13.5M | $13.8M | ||
| Q2 25 | $-13.6M | $-29.7M | ||
| Q1 25 | $-12.8M | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $-10.4M | $-7.4M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $-3.1M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | -105.1% | ||
| Q3 25 | -64.8% | 50.4% | ||
| Q2 25 | -70.5% | -101.3% | ||
| Q1 25 | -69.3% | -18.3% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | -57.8% | -19.6% | ||
| Q2 24 | — | 63.3% | ||
| Q1 24 | — | -8.7% |
| Q4 25 | -54.6% | -101.7% | ||
| Q3 25 | -59.6% | 54.4% | ||
| Q2 25 | -64.4% | -98.5% | ||
| Q1 25 | -62.4% | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | -60.6% | -20.0% | ||
| Q2 24 | — | 63.9% | ||
| Q1 24 | — | -7.9% |
| Q4 25 | $-0.35 | $-0.49 | ||
| Q3 25 | $-0.37 | $0.12 | ||
| Q2 25 | $-0.38 | $-0.53 | ||
| Q1 25 | $-0.36 | $-0.15 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-1.85 | $-0.19 | ||
| Q2 24 | — | $0.29 | ||
| Q1 24 | — | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $84.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $1.2B |
| Total Assets | $195.8M | $6.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $84.6M | ||
| Q3 25 | $168.5M | $204.1M | ||
| Q2 25 | $177.4M | $107.7M | ||
| Q1 25 | $182.7M | $106.4M | ||
| Q4 24 | — | $104.9M | ||
| Q3 24 | $14.1M | $108.8M | ||
| Q2 24 | — | $107.2M | ||
| Q1 24 | — | $106.5M |
| Q4 25 | $155.3M | $1.2B | ||
| Q3 25 | $164.1M | $1.2B | ||
| Q2 25 | $172.2M | $1.2B | ||
| Q1 25 | $180.9M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $-136.0M | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $195.8M | $6.5B | ||
| Q3 25 | $199.5M | $6.5B | ||
| Q2 25 | $207.7M | $6.8B | ||
| Q1 25 | $213.5M | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | $47.1M | $6.8B | ||
| Q2 24 | — | $7.1B | ||
| Q1 24 | — | $7.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $72.3M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $72.3M | ||
| Q3 25 | $-11.1M | $18.5M | ||
| Q2 25 | $-7.5M | $21.1M | ||
| Q1 25 | $-11.4M | $15.9M | ||
| Q4 24 | — | $132.6M | ||
| Q3 24 | — | $49.1M | ||
| Q2 24 | — | $30.6M | ||
| Q1 24 | — | $34.5M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
KREF
Segment breakdown not available.
